Download Citation
Article Source:
Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types
Zhang M,
Kim YW,
Yang CX,
Gauvreau GM,
FitzGerald JM,
et al.
(2026)
Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types.
PLOS Computational Biology 22(4): e1014081.
https://doi.org/10.1371/journal.pcbi.1014081